Conference item icon

Conference item

PROTECT-1 Study Demonstrated Efficacy of the Intestine-Specific Chemokine Receptor Antagonist CCX282-B (Traficet-EN) in Treatment of Patients with Moderate to Severe Crohn's Disease

Publication status:
Published

Actions

Authors

More by this author
Institution:
University of Oxford
Division:
MSD
Department:
NDM
Sub department:
NDM Experimental Medicine
Role:
Author


Host title:
GASTROENTEROLOGY
Volume:
136
Issue:
5
Pages:
A65-A65
Publication date:
2009-05-01
ISSN:
0016-5085


Pubs id:
pubs:66869
UUID:
uuid:f365a72e-1653-43af-b270-3f9f2ffccb6e
Local pid:
pubs:66869
Source identifiers:
66869
Deposit date:
2012-12-19
ARK identifier:

Terms of use


Views and Downloads






If you are the owner of this record, you can report an update to it here: Report update to this record

TO TOP